Search

Learn about new findings regarding how inherited and acquired genetic mutations cause breast cancer resistance to certain therapies.

… Wednesday, March 4, 2026 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in  breast cancer patients can interact and drive resistance to certain drugs called CDK4/6 inhibitors. This finding, published in  Nature , suggests a new

Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.

… Saturday, September 26, 2015 Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer. In the studies,

Catch up with some of the patients we got to know in 2017.

… Thursday, December 28, 2017 Everyone touched by cancer has a story to tell. We reconnected with just a few of the inspiring people we met in 2017 to see how they’re doing today. Tim Waples It’s been five years since Tim, a special education teacher from Emerson, New Jersey, completed treatment for non-Hodgkin

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

… Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Gallbladder

The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.

… Friday, January 4, 2019 Summary This wide-ranging effort, which was jointly funded by the National Human Genome Research Institute and the National Cancer Institute, has been completed. When The Cancer Genome Atlas (TCGA) launched in 2005, the understanding of the genetic changes that drive cancer was

Experts from Memorial Sloan Kettering presented some of the latest research on this challenging complication of many cancer surgeries.

… Friday, December 7, 2018 Summary Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after cancer surgery. It can greatly impact a person’s quality of life. Cancer-related lymphedema is one of the most challenging long-term side effects that can occur after

MSK head and neck surgeons are investigating novel imaging methods that enable them to detect and visualize cancer cells during an operation.

… Thursday, August 17, 2017 Summary Surgery for head and neck cancers is challenging due to the presence of critical nerves and blood vessels near the tumors. MSK surgeons are exploring several new imaging techniques that detect and illuminate cancer cells during the operation. This will enable surgeons

Find out what it’s like to undergo cancer treatment when you work at a cancer hospital like Memorial Sloan Kettering.

… Monday, October 8, 2018 Summary As Director of Case Management at Memorial Sloan Kettering, Laura Ostrowsky oversees discharge planning and follow-up care for people leaving the hospital. She has held the role for 19 years. She was diagnosed with early-stage breast cancer in January 2018 and was treated

Following surgery to remove NF2 tumors in her brain, MSK patient Maggie Chess developed a sudden passion and talent for abstract painting, a rare outcome that has transformed her life.

… Wednesday, July 30, 2025 Maggie Chess holds a special place in her heart for the neurosurgeons at Memorial Sloan Kettering Cancer Center (MSK). Brain surgery at MSK, in 2021, saved Maggie’s life and gave her family much needed hope. But what makes Maggie’s case extraordinary is what she discovered post-surgery

Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center.

… Wednesday, December 1, 2021 Saad Usmani, MD, has been named Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK). He joins MSK from the Levine Cancer Center in North Carolina and succeeds C. Ola Landgren, MD, PhD, who previously served in this role for six years. Dr. Usmani is